| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/22/2004 | US20040077567 Antisense modulation of CD36 expression |
| 04/22/2004 | US20040077085 Antisense modulation of CDC14A expression |
| 04/22/2004 | US20040077084 Antisense modulation of histone deacetylase 4 expression |
| 04/22/2004 | US20040077083 For treatment of diseases associated with expression of Histone deacetylase 4 such as leukemia |
| 04/22/2004 | US20040077082 Oligonucleotides with 5'- and 3'-terminal hairpins that may be configured to regulate the expression of a gene |
| 04/22/2004 | US20040077074 Multi-chambered analysis device |
| 04/22/2004 | US20040077064 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 04/22/2004 | US20040077049 For preventing, ameliorating, disorders or diseases including cancer, peripheral and central nervous system disorders, genitourinary disorders, cardiovascular disorders, and Chronic obstructive pulmonary (or airways) disease (COPD) |
| 04/22/2004 | US20040077048 Used in the diagnosis, treatment, and prevention of gastrointestinal, cardiovascular, autoimmune/ inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 04/22/2004 | US20040077044 Nucleic acid and amino acid sequences of kinases and phosphatases and use of these sequences in the diagnosis, treatment, and prevention of cardiovascular diseases, immune system disorders, neurological disorders, cancer |
| 04/22/2004 | US20040077015 Detection of Mycoplasma in patients with chronic fatigue syndrome and related disorders |
| 04/22/2004 | US20040077012 Thermostable DNA polymerases that can serve as chromosomal replicases and are derived from thermophilic bacteria |
| 04/22/2004 | US20040077002 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty; atherosclerosis |
| 04/22/2004 | US20040076998 Sequencing method using magnifying tags |
| 04/22/2004 | US20040076990 Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection |
| 04/22/2004 | US20040076988 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes |
| 04/22/2004 | US20040076981 Fungal gene cluster associated with pathogenesis |
| 04/22/2004 | US20040076971 UV excitable fluorescent energy transfer dyes |
| 04/22/2004 | US20040076970 Human cytoplasmic polyadenylation element binding protein and uses thereof |
| 04/22/2004 | US20040076963 Contacting the functionalized front surface of a metal substrate with linker molecules each having a group which binds to the surface (e.g., an alkoxysilane) and contacting the surface with probes to bind them to the front surface |
| 04/22/2004 | US20040076958 Methods and compositions for the treatment of Alzheimer's disease and other neurodegenerative disorders |
| 04/22/2004 | US20040076638 Methods for preparing bacillus anthracis protective antigen for use in vaccines |
| 04/22/2004 | US20040076636 HIV immunogenic complexes |
| 04/22/2004 | DE10247790A1 Solid phase synthesis of labelled oligonucleotide conjugate, by nucleophilic substitution of labile protecting group on terminal hydroxy group with labeling reagent |
| 04/22/2004 | CA2823937A1 Hiv vaccine formulations |
| 04/22/2004 | CA2820949A1 Novel immunogenic proteins of leptospira |
| 04/22/2004 | CA2501939A1 Novel immunogenic proteins of leptospira |
| 04/22/2004 | CA2501752A1 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | CA2501476A1 Hiv vaccine formulations |
| 04/22/2004 | CA2501459A1 Production of homotrimeric fusion proteins |
| 04/22/2004 | CA2501078A1 A transgenic animal comprising a gene operably linked to a cell cycle activated promoter |
| 04/22/2004 | CA2500741A1 Glucose transport mutants for production of biomaterial |
| 04/21/2004 | EP1411124A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/21/2004 | EP1411063A1 Peptide nucleic acids |
| 04/21/2004 | EP1409738A1 Methods and oligonucleotides for the detection of salmonella sp.,e.coli o157:h7,and listeria monocytogenes |
| 04/21/2004 | EP1409737A2 Methods for detecting and treating the early onset of aging-related conditions |
| 04/21/2004 | EP1409735A1 Dual resonance energy transfer nucleic acid probes |
| 04/21/2004 | EP1409725A2 Diagnosis and treatment of blood disorders |
| 04/21/2004 | EP1409723A2 Method of determining dihydropyrimidine dehydrogenase gene expression |
| 04/21/2004 | EP1409718A2 Canine toxicity genes |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | EP1409668A2 Antisense nucleic acid against alphav integrin |
| 04/21/2004 | EP1409548A2 Ligands to enhance cellular uptake of biomolecules |
| 04/21/2004 | EP1409507A2 Compositions, methods and kits relating to remodelin |
| 04/21/2004 | EP1409506A1 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
| 04/21/2004 | EP1409505A1 Multimer polynucleotide synthesis |
| 04/21/2004 | EP1409017A2 Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications |
| 04/21/2004 | EP1339732A4 Specific double-stranded probes for homogeneous detection of nucleic acid and their application methods |
| 04/21/2004 | EP1252339B1 Synthesis of spatially addressed molecular arrays |
| 04/21/2004 | EP1117678B1 Solid phase synthesis, whereby the solid phase consists of two different substrates |
| 04/21/2004 | EP1071701A4 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 04/21/2004 | EP0980378B1 Method for detecting the presence of biological matters of bovine origin, and oligonucleotides for its implementation |
| 04/21/2004 | EP0931090B1 Improved chimeric oligonucleotide vectors |
| 04/21/2004 | EP0815218B1 Human vegf-specific antisense oligonucleotides |
| 04/21/2004 | EP0641215B1 Protease-resistant thrombomodulin analogs |
| 04/21/2004 | CN1491278A Lipase variants |
| 04/21/2004 | CN1490325A Human gene RHBDL2 related to nervous system development |
| 04/21/2004 | CN1490324A Human gene NETRIN-G2 related to nervous system development |
| 04/21/2004 | CN1490323A Genome sequence of O-foot and mouth disease virus NYOO lines |
| 04/21/2004 | CN1146668C Oligonucleotide tags for sorting and identification |
| 04/21/2004 | CN1146662C Movbillivirus L4 strain fusion protein gene |
| 04/21/2004 | CN1146661C Morbillivirus L4 strain hemagglutinin gene |
| 04/20/2004 | US6723893 Mice having a mutant SOD-1-encoding transgene |
| 04/20/2004 | US6723841 Corticotropin-releasing factor2 receptors |
| 04/20/2004 | US6723832 Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
| 04/20/2004 | US6723706 Modified antisense nucleotides complementary to a section of the human Ha-ras gene |
| 04/20/2004 | US6723535 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 04/20/2004 | US6723515 Polyamide for use tool in the adjustment of the migration of nucleotide sequences during electrophoresis |
| 04/20/2004 | US6723513 Sequencing method using magnifying tags |
| 04/20/2004 | US6723505 Method for identification of the indicators of contamination in liquid samples |
| 04/16/2004 | CA2408207A1 Peptides binding protein phosphatase 2a and polynucleotides coding them |
| 04/15/2004 | WO2004031402A2 Methylation profile of cancer |
| 04/15/2004 | WO2004031362A2 Multimeric protein engineering |
| 04/15/2004 | WO2004031354A2 Human sarcoma-associated antigens |
| 04/15/2004 | WO2004031351A2 Microarrays having multiple oligonucleotides in single array features |
| 04/15/2004 | WO2004031210A2 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | WO2004031208A2 Promoter sequences for corticotropin releasing factor binding protein and use thereof |
| 04/15/2004 | WO2004031105A2 Use of a33 antigens and jam-it |
| 04/15/2004 | WO2004030616A2 Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES |
| 04/15/2004 | WO2003097794A3 Universal-tagged oligonucleotide primers and methods of use |
| 04/15/2004 | WO2003091304A3 Solid supports functionalised by phosphorus dendrimers, method for preparing same and uses thereof |
| 04/15/2004 | WO2003018823A8 Obesity related genes expressed at least in the hypotalamus, liver or pancreas |
| 04/15/2004 | WO2003018776A9 IDENTIFICATION OF THE IκBNS PROTEIN AND ITS PRODUCTS |
| 04/15/2004 | US20040073021 Cloning and sequencing of the porcine interleukin-12 receptor beta-1 and beta-2 chains |
| 04/15/2004 | US20040073018 Comprises nucleotide seuences coding enzyme which catalyzes methylation of homocysteine to methionine for diagnosis and treatment of hyperhomocysteinemia, nervous system, and cell proliferative disorders |
| 04/15/2004 | US20040073017 Surface modification, linker attachment, and polymerization methods |
| 04/15/2004 | US20040072786 Oligonucleotides specifically hybridizable with mRNA encoding human H-ras, Ki-ras and N-ras; antiproliferative; cancer |
| 04/15/2004 | US20040072785 Ischemia; polynucleotide for transfection; polynucleotide is inserted into an artery or a vein; prior to injection the volume of the muscle tissue is increased such that the genetic material is delivered to the parenchymal cell |
| 04/15/2004 | US20040072340 Use of peptide vectors to improve the immune response to antigens |
| 04/15/2004 | US20040072321 Alkaline protease |
| 04/15/2004 | US20040072304 Preparing dealkylated nucleotide sequences and diagnosing autoimmune and inflammatory sequences |
| 04/15/2004 | US20040072297 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives |
| 04/15/2004 | US20040072290 Transgenic cells expressing anti-human squamous-cell carcinoma monoclonal antibody with enhanced antibody dependent cellular cytotoxicity (ADCC); drug targeting and delivery |
| 04/15/2004 | US20040072289 Comprises nucleotide sequences coding transcriptional regulatory protein for generation and propagation drought, freeze and salt resistant plants; tissue engineering |
| 04/15/2004 | US20040072235 Cytochrome P450 genetic variations |
| 04/15/2004 | US20040072234 High affinity nucleic acid ligands to lectins |
| 04/15/2004 | US20040072231 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 04/15/2004 | US20040072226 Movement of multi-enzymatic nanoassemblies on recognition landscapes |
| 04/15/2004 | US20040072215 Solid-phase nucleic acid isolation |
| 04/15/2004 | US20040072209 Methods of labelling polynucleotides with dibenzorhodamine dyes |